Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 15 of 17 items.

" " Acid Reducer (2021-01-29)
Acid Reducer (2021-01-29) Starting date: January 29, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type I Source of recall: Health Canada…
RecallHealth product recall | 2021-01-29
" " Sandoz Hydrocortisone (2021-01-28)
Sandoz Hydrocortisone (2021-01-28) Starting date: January 28, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall:…
RecallHealth product recall | 2021-01-28
" " PMS-Docusate Sodium(2021-01-26)
PMS-Docusate Sodium(2021-01-26) Starting date: January 26, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall: Health…
RecallHealth product recall | 2021-01-26
" " COSMONAUT BLUE (2021-01-22)
COSMONAUT BLUE (2021-01-22) Starting date: January 22, 2021 Type of communication: Drug Recall Subcategory: Veterinary Drugs Hazard classification: Type III Source of recall:…
RecallHealth product recall | 2021-01-22
" " Blue Velvet Teat Dip(2021-01-22)
Blue Velvet Teat Dip(2021-01-22) Starting date: January 22, 2021 Type of communication: Drug Recall Subcategory: Veterinary Drugs Hazard classification: Type III Source of…
RecallHealth product recall | 2021-01-22
" " 30ml Reduced-Glutathione 200mg/ml (2020-01-21)
30ml Reduced-Glutathione 200mg/ml (2020-01-21) Starting date: January 21, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type I Source of…
RecallHealth product recall | 2021-01-21
" " GILENYA (fingolimod) - Risk of Liver Injury
GILENYA (fingolimod) - Risk of Liver Injury Starting date: January 18, 2021 Posting date: January 18, 2021 Type of communication: Dear Healthcare Professional Letter…
AlertHealth professional risk communication | 2021-01-18
" " PurGerme(2021-01-15)
PurGerme(2021-01-15) Starting date: January 15, 2021 Type of communication: Drug Recall Subcategory: Natural health products Hazard classification: Type II Source of recall:…
RecallHealth product recall | 2021-01-15
" " Pregabalin 150mg(2020-01-15)
Pregabalin 150mg(2020-01-15) Starting date: January 15, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall: Health…
RecallHealth product recall | 2021-01-15
" " PMS-Pregabalin 150mg(2020-01-15)
PMS-Pregabalin 150mg(2020-01-15) Starting date: January 15, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall: Health…
RecallHealth product recall | 2021-01-15
" " Sandoz Irbesartan HCT(2021-01-12)
Sandoz Irbesartan HCT(2021-01-12) Starting date: January 12, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall: Health…
RecallHealth product recall | 2021-01-12
" " Irbesartan-HCTZ (2021-01-12)
Irbesartan-HCTZ (2021-01-12) Starting date: January 12, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type II Source of recall: Health…
RecallHealth product recall | 2021-01-12
" " Acid Reducer (2021-01-08)
Acid Reducer (2021-01-08) Starting date: January 8, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type I Source of recall: Health Canada…
RecallHealth product recall | 2021-01-08
" " E-Fect (2021-01-07)
E-Fect (2021-01-07) Starting date: January 7, 2021 Type of communication: Drug Recall Subcategory: Drugs Hazard classification: Type III Source of recall: Health Canada Issue…
RecallHealth product recall | 2021-01-07
" " Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration
Important Safety Information on SUBOXONE (buprenorphine and naloxone) and the Risk of Overdose or Underdose when Switching Between Dosage Forms or Routes of Administration…
AlertHealth professional risk communication | 2021-01-07
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.